1416-C EFFICACY AND SAFETY OF TENOFOVIR ALAFENAMIDE IN THE TREATMENT OF DECOMPENSATED CIRRHOTIC PATIENTS WITH CHRONIC HEPATITIS B You Deng 1 , Shuqian Zhang 1 , Wenya Chen 1 , Jiashuo Li 1 , Mengqi Li 1 , Qi Wang 1 , Hong Zhao 1 , Bing Qiao 2 and Wen Xie 1 , (1)Center of Liver Diseases, Beijing Ditan Hospital, Capital Medical University, Beijing, China, (2)Qingdao Sixth People's Hospital Background: Hepatitis B viral (HBV) infection is a leading cause of liver cirrhosis and hepatocellular carcinoma (HCC) worldwide
Ultrathin sections (100nm) were obtained on copper grids and stained with tannic acid and lead solution
FAQs Why is it important to gradually stop taking GLP-1 medications instead of quitting suddenly
In the body, soluble fiber binds to fatty substances and promotes their excretion as waste
This means your natural GLP-1 can work its magic even more